Earnest Analytics Crosses from Credit Cards to Medical Claims

The most valuable alternative data isn't the dataset you can buy. It's the dataset you can't, stitched together with the one next to it. For over a decade, Earnest Analytics has been quietly building a business on that premise, first with credit card panels, then with prescription drug data, and now, with a new medical claims dataset called Hydrus. The bet is that investors will pay for a unified view of the consumer and healthcare economy, a category the company has spent years trying to define [LinkedIn].

In April 2025, that bet found a buyer. Consumer Edge, a provider of global consumer transaction data, acquired Earnest Analytics, marking a successful exit for the New York-based firm [PR Newswire, Sept 2024]. Terms were not disclosed. The acquisition validated a long, capital-efficient build. Earnest had raised a $3.5 million Series A in 2014 and a $15 million Series B in 2019 [Crunchbase, 2026]. It grew to over 100 employees before the sale [LeadIQ, Oct 2024].

The wedge: consumer plus healthcare

Earnest's differentiation rests on its dual-sector focus. While many alt-data providers specialize in either consumer transaction data or healthcare data, Earnest offers both under one roof. Its Dash platform aggregates credit card panels, consumer goods pricing, web data, prescription drug records, and mobile location data [G2, 2025]. The February 2025 launch of Hydrus, a medical claims dataset, deepened its healthcare footprint [Pivot Investment Partners, 2025].

This breadth serves a specific client: the investor who needs to see cross-sector trends. A hedge fund analyzing a pharmaceutical company might use Earnest to track both prescription fills and consumer spending on over-the-counter alternatives. The platform's analytics layer, powered by what the company calls AI, surfaces predictions on earnings, sales growth, and market share [LinkedIn].

Capital efficiency and the exit path

Earnest's funding history shows a measured pace. The 2014 Series A and 2019 Series B were relatively modest rounds for a data-intensive business. This suggests a focus on unit economics and a capital-light model reliant on data partnerships rather than costly primary data collection. Investors included Osage Venture Partners and Greycroft [Crunchbase].

The 2025 acquisition by Consumer Edge represents a classic consolidation play. Consumer Edge gains Earnest's proprietary datasets and client relationships, folding them into its own global data offerings. For Earnest's backers, it was a clean exit after an eleven-year build.

2014 Series A | 3.5 | M USD
2019 Series B | 15 | M USD

The competitive landscape

Earnest operated in a crowded field of alternative data providers. Its most direct competitor is likely YipitData, another firm that aggregates and analyzes fragmented consumer data for investors. The competitive moat hinges on a few key points:

• Data breadth. Combining consumer transaction data with healthcare claims is a complex, regulated undertaking that creates a higher barrier to entry than a single-source dataset.
• Analyst overlay. Earnest positions itself not just as a data pipe but as a provider of "expert analysis" and "actionable insights," aiming to be a research partner [earnestanalytics.com].
• Platform integration. Data is delivered through the interactive Dash platform as well as via aggregated and row-level feeds through Snowflake and AWS, catering to both analysts and quantitative funds [Benzinga, 2024].

Where the wheels could come off

No data business is without its risks. For Earnest, and now for Consumer Edge, the primary challenges are not about the past exit but about the future integration and growth.

• Regulatory scrutiny. Healthcare data, especially claims data, operates under a thicket of regulations like HIPAA. Any misstep in data anonymization or usage could trigger significant liability and reputational damage.
• Panel quality and churn. The value of transaction data panels like Orion and Vela depends on their representativeness and stability. Panel churn can distort backtests, a critical use case for quantitative funds [earnestanalytics.com, 2026].
• Post-acquisition integration. The real test is whether Consumer Edge can successfully absorb Earnest's technology and culture without losing the client relationships and data partnerships that drove its value.

The company's answer to these risks has been a focus on what it calls "world-class" data partners and a point-in-time data architecture designed to measure the impact of panel changes [earnestanalytics.com]. Its acquisition suggests that at least one sophisticated buyer believed those defenses were sufficient.

The next twelve months

The immediate future for Earnest Analytics is one of integration. Its teams and products are now part of Consumer Edge's broader portfolio. The strategic question is whether the combined entity can use Earnest's healthcare datasets to win larger, cross-asset mandates from institutional investors.

Key milestones to watch will be any announced product integrations, client wins attributed to the combined offering, and potential attrition of Earnest's original leadership team. The launch of Hydrus just months before the acquisition indicates product momentum that Consumer Edge will likely seek to accelerate.

Earnest's journey from a 2012 startup to a 2025 acquisition was funded by a $3.5 million A-round led by undisclosed investors and a $15 million B-round, with backing from firms like Greycroft. It built a 100-person team to stitch together credit card swipes and medical claims into a single narrative for investors. The sale to Consumer Edge closed the chapter on its venture-backed life. Now, the question is whether the combined data stack can command a premium in a market that is still learning how to price the intersection of a consumer's wallet and their health.

Sources

1. [LinkedIn] Earnest Analytics company description | https://www.linkedin.com/company/earnest-analytics
2. [PR Newswire, Sept 2024] Consumer Edge to Acquire Earnest Analytics | https://finance.yahoo.com/news/consumer-edge-acquire-earnest-analytics-163000210.html
3. [Crunchbase, 2026] Earnest Analytics funding rounds
4. [LeadIQ, Oct 2024] Earnest Analytics employee count
5. [G2, 2025] Earnest Analytics Products
6. [Pivot Investment Partners, 2025] Hydrus medical claims dataset launch
7. [Benzinga, 2024] Earnest Analytics data delivery methods
8. [earnestanalytics.com, 2026] Company product and risk disclosures